Literature DB >> 27018977

Association of the Precursor of Interleukin-1β and Peritoneal Inflammation-Role in Pathogenesis of Endometriosis.

Justyna Sikora1, Aleksandra Mielczarek-Palacz2, Zdzisława Kondera-Anasz2.   

Abstract

BACKGROUND: The most important proinflammatory cytokine is interleukin (IL)-1β, however its precursor, prointerleukin-1β (proIL-1β), can also potentiate inflammatory state. The aim of this study was to explore the involvement of proIL-1β in pathogenesis of endometriosis. For this purpose, we evaluated concentrations of proIL-1β, IL-1β, and soluble IL-1 receptor type 2 (sIL-1R2) in peritoneal fluid (PF) and macrophage culture medium of women with endometriosis.
METHODS: PF from 55 women with and without endometriosis was collected during laparoscopy. Peritoneal macrophages were cultured in basal and stimulated with lipopolysaccharide (LPS) conditions. Concentrations of cytokines were measured with enzyme-linked immunosorbent assays (ELISA).
RESULTS: PF proIL-1β and IL-1β levels in endometriosis women were higher than in the control. Higher basal and stimulated macrophage secretion of cytokines in endometriosis patients than in the control was observed. However, in endometriosis, there was a higher level of proIL-1β than for the mature molecule. Additionally, lower PF and macrophages culture medium sIL-1R2 levels were observed in women with endometriosis.
CONCLUSIONS: Abnormal proIL-1β concentration in PF and higher macrophage secretion can escalate peritoneal inflammation and endometriosis formation. The results are presented as a total IL-1β, which is a sum of proIL-1β  and IL-1β, and we believe that it reflects the actual cytokine production. The imbalance among all studied cytokines in endometriosis may be linked with an ability to transform acute inflammation to the chronic inflammation.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  IL-1β; endometriosis; macrophages; peritoneal fluid; proIL-1β

Mesh:

Substances:

Year:  2016        PMID: 27018977      PMCID: PMC6807114          DOI: 10.1002/jcla.21944

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  22 in total

1.  Imbalance in cytokines from interleukin-1 family - role in pathogenesis of endometriosis.

Authors:  Justyna Sikora; Aleksandra Mielczarek-Palacz; Zdzislawa Kondera-Anasz
Journal:  Am J Reprod Immunol       Date:  2012-04-26       Impact factor: 3.886

Review 2.  The interleukin-1 family: back to the future.

Authors:  Cecilia Garlanda; Charles A Dinarello; Alberto Mantovani
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

3.  Revised American Society for Reproductive Medicine classification of endometriosis: 1996.

Authors: 
Journal:  Fertil Steril       Date:  1997-05       Impact factor: 7.329

Review 4.  The human P2X7 receptor and its role in innate immunity.

Authors:  J S Wiley; R Sluyter; B J Gu; L Stokes; S J Fuller
Journal:  Tissue Antigens       Date:  2011-11

Review 5.  Endometrial seedlings. A survival instinct? Immunomodulation and its role in the pathophysiology of endometriosis.

Authors:  M Portelli; J Pollacco; K Sacco; P Schembri-Wismayer; J Calleja-Agius
Journal:  Minerva Ginecol       Date:  2011-12

Review 6.  The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense.

Authors:  Aisling Dunne; Luke A J O'Neill
Journal:  Sci STKE       Date:  2003-02-25

Review 7.  Pathogenic mechanisms in endometriosis-associated infertility.

Authors:  Sajal Gupta; Jeffrey M Goldberg; Nabil Aziz; Eric Goldberg; Natalie Krajcir; Ashok Agarwal
Journal:  Fertil Steril       Date:  2008-08       Impact factor: 7.329

Review 8.  Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy?

Authors:  Ron N Apte; Elena Voronov
Journal:  Immunol Rev       Date:  2008-04       Impact factor: 12.988

9.  Imbalance in the peritoneal levels of interleukin 1 and its decoy inhibitory receptor type II in endometriosis women with infertility and pelvic pain.

Authors:  Ali Akoum; Mahéra Al-Akoum; André Lemay; Rodolphe Maheux; Mathieu Leboeuf
Journal:  Fertil Steril       Date:  2007-10-24       Impact factor: 7.329

10.  Structure of the activating IL-1 receptor signaling complex.

Authors:  Christoph Thomas; J Fernando Bazan; K Christopher Garcia
Journal:  Nat Struct Mol Biol       Date:  2012-03-18       Impact factor: 15.369

View more
  18 in total

1.  Intrafollicular inflammatory cytokines but not steroid hormone concentrations are increased in naturally matured follicles of women with proven endometriosis.

Authors:  Gengxiang Wu; N A Bersinger; M D Mueller; M von Wolff
Journal:  J Assist Reprod Genet       Date:  2017-01-10       Impact factor: 3.412

2.  A randomized trial assessing the efficacy of Silymarin on endometrioma-related manifestations.

Authors:  Negin Mirzaei; Shahideh Jahanian Sadatmahalleh; Safoura Rouholamin; Malihe Nasiri
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

3.  Tumor necrosis factor alfa and interleukin 1 alfa induced phosphorylation and degradation of inhibitory kappa B alpha are regulated by estradiol in endometrial cells.

Authors:  Sefa Arlıer; Ümit Ali Kayışlı; Aydın Arıcı
Journal:  Turk J Obstet Gynecol       Date:  2018-03-29

4.  Rate of replenishment and microenvironment contribute to the sexually dimorphic phenotype and function of peritoneal macrophages.

Authors:  C C Bain; D A Gibson; N J Steers; K Boufea; P A Louwe; C Doherty; V González-Huici; R Gentek; M Magalhaes-Pinto; T Shaw; M Bajénoff; C Bénézech; S R Walmsley; D H Dockrell; P T K Saunders; N N Batada; S J Jenkins
Journal:  Sci Immunol       Date:  2020-06-19

Review 5.  PPARγ Agonists: Emergent Therapy in Endometriosis.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Alain Le Blanche; Yves Lecarpentier
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-06

6.  Network Pharmacology-Based Prediction of Bioactive Compounds and Potential Targets of Wenjing Decoction for Treatment of Endometriosis.

Authors:  Yu-Nan Liu; Xiao-Jing Hu; Bei Liu; Yu-Jie Shang; Wen-Ting Xu; Hui-Fang Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-24       Impact factor: 2.629

Review 7.  Uterine Microbiota: Residents, Tourists, or Invaders?

Authors:  James M Baker; Dana M Chase; Melissa M Herbst-Kralovetz
Journal:  Front Immunol       Date:  2018-03-02       Impact factor: 7.561

8.  Inflammatory cytokine profile of co‑cultivated primary cells from the endometrium of women with and without endometriosis.

Authors:  Adriana Luckow Invitti; Eduardo Schor; Rafael Martins Parreira; Alexander Kopelman; Gil Kamergorodsky; Giovana Aparecida Gonçalves; Manoel João Batista Castello Girão
Journal:  Mol Med Rep       Date:  2018-06-06       Impact factor: 2.952

9.  CYP17A1 rs743572 polymorphism might contribute to endometriosis susceptibility: evidences from a case-control study.

Authors:  Lili Cong; Qiang Fu; Tianming Gao
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

10.  Interleukin-1/-33 Signaling Pathways as Therapeutic Targets for Endometriosis.

Authors:  Toru Kato; Koubun Yasuda; Kazufumi Matsushita; Ken J Ishii; Seiichi Hirota; Tomohiro Yoshimoto; Hiroaki Shibahara
Journal:  Front Immunol       Date:  2019-08-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.